| 摘要 |
The present invention relates to methods of determining genetic predisposition to type 2 diabetes and/or insulin resistance and to methods of treating type 2 diabetes and/or insulin resistance and related conditions, such as obesity. The invention relates to methods of determining an individual's predisposition to diabetes and/or insulin resistance by typing the LPIN2 gene or the LPIN2 protein. The invention also relates to associated methods, use and treatments. |
